DOI: 10.36347/sjmcr.2023.v11i02.002

Pages: 79-108

Psychopharmacological disorders are among the leading cause of non-fatal disease burden in India. One in seven Indians was affected by psychopharmacological disorders. Although psychopharmacological agents is used for the management of psychological disorders like anxiety, psychosis, depression and mania it may side effects such as tardative dyskinesia, weight gain, weight loss, muscle cramps, dysphoria, gastrointestinal upset, eye problems or problems with blood tests. In this present review we made an exposure regarding many screening methods on evaluation of psychopharmacological disorders like anxiety, depression, psychosis and mania in the aspects of preclinical studies. These methods are very useful to evaluate the psychopharmacological agents like anti-anxiety agents, anti-psychotics, anti-depressants and anti-manic agents.